Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes

BACKGROUND: Due to its neurotoxic properties, oligomeric alpha-synuclein (α-syn) has been suggested as an attractive target for passive immunization against Parkinson’s disease (PD). In mouse models of PD, antibody treatment has been shown to lower the levels of pathogenic α-syn species, including o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gustafsson, Gabriel, Lindström, Veronica, Rostami, Jinar, Nordström, Eva, Lannfelt, Lars, Bergström, Joakim, Ingelsson, Martin, Erlandsson, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725978/
https://www.ncbi.nlm.nih.gov/pubmed/29228971
http://dx.doi.org/10.1186/s12974-017-1018-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725978/
https://www.ncbi.nlm.nih.gov/pubmed/29228971
http://dx.doi.org/10.1186/s12974-017-1018-z

Ejemplares similares